QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 22 July 2003
doi: 10.1242/jcs.00662

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.00662v1 116/17/3591    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carter, N. M. Articles by Kirby, J. A. Search for Related Content PubMed PubMed Citation Articles by Carter, N. M. Articles by Kirby, J. A. Social Bookmarking                         What's this?

Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate

¹ Applied Immunobiology Research Group, Department of Surgery, University of Newcastle, The Medical School, Newcastle upon Tyne NE2 4HH, UK
² Institute of Pharmacy, Chemistry and Biomedical Science, University of Sunderland, Sunderland SR1 3SD, UK

^* Author for correspondence (e-mail: j.a.kirby{at}ncl.ac.uk)

Accepted 12 May 2003

Heparan sulphate N-deacetylase/N-sulphotransferase (NDST) enzymes catalyse the reaction that initiates sulphation and subsequent modification of the oligosaccharide, heparan sulphate (HS). The extent and distribution of sulphate substitution on HS plays a vital role in regulation of the binding of a range of proteins, including IFN-, several interleukins and most chemokines. In this study, the expression of NDST transcripts was found to be non-uniform between a range of cell types, suggesting that different cells produce characteristic HS species. It was found that stimulation of the HMEC-1 microvascular endothelial cell line with the pro-inflammatory cytokines IFN- and TNF- caused a transient decrease in the level of NDST-1 and -2 transcripts after 4 hours (P<0.05 and P<0.01 respectively), but the expression of NDST-1 increased above control levels after 16 hours (P<0.01). The change in NDST expression was concurrent with an increase in the abundance of sulphated HS epitopes on the cell surface; this was not caused by variation in the expression of proteoglycans or by changes in the rate of GAG turnover. Cytokine-stimulated endothelial cells also showed an increase in their potential to bind RANTES (CCL5); this was abrogated by chlorate blockade of sulphotransferase activity or by heparitinase cleavage of cell surface HS. Monolayers of cytokine-stimulated HMEC-1 also supported an enhanced leukocyte chemotactic response towards RANTES. This study demonstrated that pro-inflammatory cytokines can increase NDST expression leading to increased sulphation of HS and a corresponding increase in sequestration of functional RANTES at the apical surface of endothelial cells. This may enhance leukocyte extravasation at sites of inflammation.

Key words: Heparan sulphate, Inflammation, Chemokine, IFN-, TNF-, RANTES

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. W. A. M. Celie, R. M. Reijmers, E. M. Slot, R. H. J. Beelen, M. Spaargaren, P. M. ter Wee, S. Florquin, and J. van den Born Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria Am J Physiol Renal Physiol, January 1, 2008; 294(1): F253 - F263. [Abstract] [Full Text] [PDF]

				K. S. Jones, C. Petrow-Sadowski, D. C. Bertolette, Y. Huang, and F. W. Ruscetti Heparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T Cells J. Virol., October 15, 2005; 79(20): 12692 - 12702. [Abstract] [Full Text] [PDF]

				N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 892 - 898. [Abstract] [Full Text] [PDF]

				S. Ali, H. Robertson, J. H. Wain, J. D. Isaacs, G. Malik, and J. A. Kirby A Non-Glycosaminoglycan-Binding Variant of CC Chemokine Ligand 7 (Monocyte Chemoattractant Protein-3) Antagonizes Chemokine-Mediated Inflammation J. Immunol., July 15, 2005; 175(2): 1257 - 1266. [Abstract] [Full Text] [PDF]